1.
|
Yoo CH, Noh SH, Shin DW, Choi SH and Min
JS: Recurrence following curative resection for gastric carcinoma.
Br J Surg. 87:236–242. 2000. View Article : Google Scholar : PubMed/NCBI
|
2.
|
Fujiwara Y, Doki Y, Taniguchi H, et al:
Genetic detection of free cancer cells in the peritoneal cavity of
the patient with gastric cancer: present status and future
perspectives. Gastric Cancer. 10:197–204. 2007. View Article : Google Scholar : PubMed/NCBI
|
3.
|
Semenza GL: Defining the role of
hypoxia-inducible factor 1 in cancer biology and therapeutics.
Oncogene. 29:625–634. 2010. View Article : Google Scholar : PubMed/NCBI
|
4.
|
Nakamura J, Kitajima Y, Kai K, et al:
HIF-1alpha is an unfavorable determinant of relapse in gastric
cancer patients who underwent curative surgery followed by adjuvant
5-FU chemotherapy. Int J Cancer. 127:1158–1171. 2010. View Article : Google Scholar : PubMed/NCBI
|
5.
|
Broll R, Weschta M, Windhoevel U, et al:
Prognostic significance of free gastrointestinal tumor cells in
peritoneal lavage detected by immunocytochemistry and polymerase
chain reaction. Langenbecks Arch Surg. 386:285–292. 2001.
View Article : Google Scholar
|
6.
|
Lee CC, Lo SS, Wu CW, et al: Peritoneal
recurrence of gastric adenocarcinoma after curative resection.
Hepatogastroenterology. 50:1720–1722. 2003.PubMed/NCBI
|
7.
|
Stoeltzing O, McCarty MF, Wey JS, et al:
Role of hypoxiainducible factor 1alpha in gastric cancer cell
growth, angiogenesis, and vessel maturation. J Natl Cancer Inst.
96:946–956. 2004. View Article : Google Scholar : PubMed/NCBI
|
8.
|
Dang DT, Chen F, Gardner LB, et al:
Hypoxia-inducible factor-1alpha promotes nonhypoxia-mediated
proliferation in colon cancer cells and xenografts. Cancer Res.
66:1684–1693. 2006. View Article : Google Scholar : PubMed/NCBI
|
9.
|
Tang N, Wang L, Esko J, et al: Loss of
HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF
autocrine loop necessary for tumorigenesis. Cancer Cell. 6:485–495.
2004. View Article : Google Scholar : PubMed/NCBI
|
10.
|
Pfander D, Cramer T, Schipani E and
Johnson RS: HIF-1alpha controls extracellular matrix synthesis by
epiphyseal chondrocytes. J Cell Sci. 116:1819–1826. 2003.
View Article : Google Scholar : PubMed/NCBI
|
11.
|
Carmeliet P, Dor Y, Herbert JM, et al:
Role of HIF-1alpha in hypoxia-mediated apoptosis, cell
proliferation and tumour angiogenesis. Nature. 394:485–490. 1998.
View Article : Google Scholar : PubMed/NCBI
|
12.
|
Blouw B, Song H, Tihan T, et al: The
hypoxic response of tumors is dependent on their microenvironment.
Cancer Cell. 4:133–146. 2003. View Article : Google Scholar : PubMed/NCBI
|
13.
|
Liotta LA: Tumor invasion and metastases –
role of the extra-cellular matrix: Rhoads Memorial Award lecture.
Cancer Res. 46:1–7. 1986.
|
14.
|
Fujimoto D, Hirono Y, Goi T, Katayama K
and Yamaguchi A: Prognostic value of protease-activated receptor-1
(PAR-1) and matrix metalloproteinase-1 (MMP-1) in gastric cancer.
Anticancer Res. 28:847–854. 2008.PubMed/NCBI
|
15.
|
Yoshikawa T, Yanoma S, Tsuburaya A, et al:
Expression of MMP-7 and MT1-MMP in peritoneal dissemination of
gastric cancer. Hepatogastroenterology. 53:964–967. 2006.PubMed/NCBI
|
16.
|
Mizutani K, Kofuji K and Shirouzu K: The
significance of MMP-1 and MMP-2 in peritoneal disseminated
metastasis of gastric cancer. Surg Today. 30:614–621. 2000.
View Article : Google Scholar : PubMed/NCBI
|
17.
|
Yonemura Y, Endou Y, Fujita H, et al: Role
of MMP-7 in the formation of peritoneal dissemination in gastric
cancer. Gastric Cancer. 3:63–70. 2000. View Article : Google Scholar : PubMed/NCBI
|
18.
|
Yonemura Y, Endo Y, Fujita H, et al:
Inhibition of peritoneal dissemination in human gastric cancer by
MMP-7-specific anti-sense oligonucleotide. J Exp Clin Cancer Res.
20:205–212. 2001.PubMed/NCBI
|
19.
|
Deng H, Guo RF, Li WM, Zhao M and Lu YY:
Matrix metal-loproteinase 11 depletion inhibits cell proliferation
in gastric cancer cells. Biochem Biophys Res Commun. 326:274–281.
2005. View Article : Google Scholar : PubMed/NCBI
|
20.
|
Zhao ZS, Chu YQ, Ye ZY, Wang YY and Tao
HQ: Overexpression of matrix metalloproteinase 11 in human gastric
carcinoma and its clinicopathologic significance. Hum Pathol.
41:686–696. 2010. View Article : Google Scholar : PubMed/NCBI
|
21.
|
Yonemura Y, Fujimura T, Ninomiya I, et al:
Prediction of peritoneal micrometastasis by peritoneal lavaged
cytology and reverse transcriptase-polymerase chain reaction for
matrix metalloproteinase-7 mRNA. Clin Cancer Res. 7:1647–1653.
2001.
|
22.
|
Yanagihara K, Takigahira M, Tanaka H, et
al: Development and biological analysis of peritoneal metastasis
mouse models for human scirrhous stomach cancer. Cancer Sci.
96:323–332. 2005. View Article : Google Scholar : PubMed/NCBI
|
23.
|
Wada N, Otani Y, Kubota T, et al: Reduced
angiogenesis in peritoneal dissemination of gastric cancer through
gelatinase inhibition. Clin Exp Metastasis. 20:431–435. 2003.
View Article : Google Scholar : PubMed/NCBI
|
24.
|
Miyoshi A, Kitajima Y, Ide T, et al:
Hypoxia accelerates cancer invasion of hepatoma cells by
upregulating MMP expression in an HIF-1alpha-independent manner.
Int J Oncol. 29:1533–1539. 2006.PubMed/NCBI
|
25.
|
Fujiwara S, Nakagawa K, Harada H, et al:
Silencing hypoxiainducible factor-1alpha inhibits cell migration
and invasion under hypoxic environment in malignant gliomas. Int J
Oncol. 30:793–802. 2007.PubMed/NCBI
|